These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Akineton psychoses]. STEINBRECHER W Dtsch Med Wochenschr; 1958 Aug; 83(33):1399-400. PubMed ID: 13573928 [No Abstract] [Full Text] [Related]
8. NEW AND nonofficial remedies: cycrimine hydrochloride. J Am Med Assoc; 1955 Feb; 157(6):510-1. PubMed ID: 13221464 [No Abstract] [Full Text] [Related]
9. [Lyseen (HH 212), a new substance for the treatment of extrapyramidal disorders and of muscle spasms of central and peripheral origin]. SCHULZ HP Munch Med Wochenschr; 1961 May; 103():1066-8. PubMed ID: 13748916 [No Abstract] [Full Text] [Related]
10. [Experiences in the treatment of parkinsonism & other extrapyramidal disorders]. KONIG JK Medizinische; 1959 Feb; 4(9):388-9. PubMed ID: 13643481 [No Abstract] [Full Text] [Related]
11. Nephrotoxicity associated with zoxazolamine administration. STREITZ JM N Engl J Med; 1959 Jun; 260(25):1278-9. PubMed ID: 13666952 [No Abstract] [Full Text] [Related]
12. Quantitative measurement of therapy in paralysis agitans. AGATE FJ; DOSHAY LJ; CURTIS FK J Am Med Assoc; 1956 Feb; 160(5):352-4. PubMed ID: 13278202 [No Abstract] [Full Text] [Related]
13. The action of 267C (1-(1-piperidyl)-6-methyl-3-phenyl-3-heptanol hydrochloride) in Parkinson's disease. GIANVITO L; JACKSON I; MCGAVACK TH J Am Geriatr Soc; 1956 Aug; 4(8):793-6. PubMed ID: 13357272 [No Abstract] [Full Text] [Related]
14. Antispasmodic compound 08958 in treatment of paralysis agitans. MAGEE KR; DEJONG RN J Am Med Assoc; 1953 Oct; 153(8):715-8. PubMed ID: 13096281 [No Abstract] [Full Text] [Related]
15. Nephropathy associated with the oral administration of zoxazolamine (flexin); report of a case. COHEN T N Engl J Med; 1957 Jun; 256(25):1193-4. PubMed ID: 13452021 [No Abstract] [Full Text] [Related]
16. Clinical observations on the relation of muscular rigidity and tremor in idiopathic paralysis agitans. PARK HW; HAJEK-NICHOLS N South Med J; 1959 Oct; 52():1246-8. PubMed ID: 14430469 [No Abstract] [Full Text] [Related]
17. [New methods of medicinal treatment of extrapyramidal disorders, with special reference to parkinsonism & postencephalitic parkinsonism]. RUTHER W; THEISS W Med Klin; 1958 Aug; 53(35):1495-7. PubMed ID: 13589544 [No Abstract] [Full Text] [Related]
18. Preliminary study of a new anti-parkinson agent. DOSHAY LJ; CONSTABLE K; FROMER S Neurology; 1952; 2(3):233-43. PubMed ID: 14929300 [No Abstract] [Full Text] [Related]
19. Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans. DOSHAY LJ J Am Med Assoc; 1956 Nov; 162(11):1031-4. PubMed ID: 13366700 [No Abstract] [Full Text] [Related]